Table 2.

Summary of the subtype-specific analyses

Ranka	Agilent ID	fb	P-value	Gene	Ranka	Agilent ID	fb	P-value	Gene	Ranka	Agilent ID	fb	P-value	Gene
(a) CLL-specific analysis
1	A_23_P500400	16.42	3.7E−81	ABCA6	21	A_23_P201211	5.41	3.0E−33	FCRL5	41	A_23_P147578	2.29	3.5E−26	–
2	A_32_P53234	5.26	4.1E−60	–	22	A_24_P376848	4.11	1.4E−32	FCRL5	42	A_32_P116989	2.20	3.6E−26	ZCCHC18
3	A_23_P26854	24.26	6.1E−60	ARHGAP44	23	A_23_P310931	2.29	2.1E−32	CNR2	43	A_23_P76402	2.10	4.8E−26	TCTN1
4	A_23_P130158	14.37	1.2E−46	WNT3	24	A_23_P46039	3.40	4.4E−32	FCRLA	44	A_23_P39067	2.36	4.9E−26	SPIB
5	A_23_P27332	3.82	3.0E−44	TCF4	25	A_23_P164773	3.39	8.1E−32	FCER2	45	A_23_P116533	2.13	7.1E−26	SWAP70
6	A_23_P131024	5.28	1.0E−43	ZBTB32	26	A_23_P160751	3.89	3.2E−31	FCRL2	46	A_23_P253321	2.35	7.5E−26	PNOC
7	A_24_P691826	5.60	2.3E−43	–	27	A_24_P402588	2.20	3.5E−31	BCL11A	47	A_23_P85269	2.98	8.5E−26	TTN
8	A_24_P29733	3.89	3.7E−41	CDK14	28	A_23_P163697	2.71	4.6E−31	SYT17	48	A_23_P259393	1.85	1.3E−25	SFMBT1
9	A_23_P67529	3.18	7.7E−41	KCNN4	29	A_23_P132378	3.35	2.0E−30	CELSR1	49	A_32_P44394	2.65	2.3E−25	AIM2
10	A_24_P931428	3.69	4.0E−37	TCF4	30	A_23_P17269	2.08	3.3E−30	CCDC88A	50	A_23_P342131	1.81	3.5E−25	CYBASC3
11	A_32_P108156	3.68	9.7E−37	MIR155HG	31	A_23_P45786	2.30	5.7E−30	COL9A2	51	A_24_P662636	3.70	8.3E−25	–
12	A_23_P145889	3.26	5.6E−36	CDK14	32	A_23_P102113	2.10	7.5E−30	WNT10A	52	A_23_P8961	2.39	9.7E−25	IL7
13	A_23_P20427	2.42	6.5E−36	RHOBTB2	33	A_23_P370830	3.92	6.3E−28	KLHL14	53	A_23_P113572	2.77	1.2E−24	CD19
14	A_32_P48054	2.86	9.2E−36	CNR2	34	A_23_P21758	2.81	1.1E−27	ADAM28	54	A_32_P107029	2.14	2.5E−24	NAPSA
15	A_23_P85250	3.01	1.5E−35	CD24	35	A_24_P184803	3.81	1.3E−27	COCH	55	A_23_P4551	2.10	6.1E−24	SETBP1
16	A_23_P156907	4.38	5.6E−35	SOBP	36	A_24_P54390	2.81	3.1E−27	RASGRP3	56	A_23_P419213	2.28	8.4E−24	KIAA1407
17	A_24_P319647	3.37	2.4E−34	FCRL2	37	A_23_P31725	3.09	4.4E−27	BLK	57	A_32_P73507	2.85	1.3E−23	CHDH
18	A_32_P49854	2.08	2.4E−34	–	38	A_24_P410605	2.96	1.4E−26	ROR1	58	A_23_P7185	2.54	4.2E−23	STAP1
19	A_23_P56553	2.59	3.1E−34	METTL8	39	A_23_P40108	3.76	2.3E−26	COL9A3	59	A_32_P72067	2.81	4.4E−23	–
20	A_23_P124335	2.90	8.2E−34	–	40	A_23_P30736	2.13	3.4E−26	HLA-DOB	60	A_23_P91764	2.17	5.6E−23	TNFRSF13C
(b) MM-specific analysis
1	A_24_P139620	0.99	2.9E−11	USP21
2	A_23_P210581	0.68	8.1E−08	KCNG1
3	A_32_P8813	0.67	4.22E−07	LOC283663

(a) lists the 60 strongest associations found for the CLL-specific analysis and (b) the three significant associations found for MM-specific analyses.

^aRank: Probes are ordered with respect to their estimated strength of association with the disease status.

^bFold-change (f) is derived from the regression coefficient estimate (β) by the mixed model: f = 2^β.